DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3DR REDDYS
02 39BAUSCH
03 2EPI HLTH
04 39JOURNEY
05 3REMPEX
01 47541347
02 47544373
03 117790705
04 117919483
05 118252776
06 118268804
07 38722650
08 28865139
09 28945516
10 28992896
11 19084802
12 29192615
13 19278105
14 29675700
15 110086080
16 110137200
17 210213512
18 210265404
19 110322186
20 110398641
21 110517882
22 110821187
23 110849847
24 110905664
25 110946101
26 211103517
27 111191740
28 111364212
29 111944634
30 112138311
01 86Blank
01 21Y
02 65Blank
01 362025-06-24
02 112027-03-07
03 82027-04-02
04 192030-10-01
05 22031-05-12
06 22031-11-17
07 12032-10-16
08 22036-04-07
09 22037-09-08
10 32039-01-07
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Patent Expiration Date : 2039-01-07
US Patent Number : 11364212
Drug Substance Claim :
Drug Product Claim :
Application Number : 219015
Patent Use Code : U-4043
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-01-07
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Patent Expiration Date : 2039-01-07
US Patent Number : 11191740
Drug Substance Claim :
Drug Product Claim :
Application Number : 219015
Patent Use Code : U-4043
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-01-07
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Patent Expiration Date : 2039-01-07
US Patent Number : 10905664
Drug Substance Claim :
Drug Product Claim :
Application Number : 219015
Patent Use Code : U-4043
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-01-07
Patent Expiration Date : 2027-04-02
US Patent Number : 7541347
Drug Substance Claim :
Drug Product Claim :
Application Number : 50808
Patent Use Code : U-917
Delist Requested :
Patent Use Description : TREATMENT OF INFLAMMAT...
Patent Expiration Date : 2027-04-02
Patent Expiration Date : 2027-03-07
US Patent Number : 7919483
Drug Substance Claim :
Drug Product Claim :
Application Number : 50808
Patent Use Code : U-1078
Delist Requested :
Patent Use Description : TREATMENT OF ACNE
Patent Expiration Date : 2027-03-07
Patent Expiration Date : 2025-06-24
US Patent Number : 8252776
Drug Substance Claim :
Drug Product Claim :
Application Number : 50808
Patent Use Code : U-124
Delist Requested :
Patent Use Description : TREATMENT OF ACNE
Patent Expiration Date : 2025-06-24
Patent Expiration Date : 2025-06-24
US Patent Number : 8268804
Drug Substance Claim :
Drug Product Claim :
Application Number : 50808
Patent Use Code : U-1078
Delist Requested :
Patent Use Description : TREATMENT OF ACNE
Patent Expiration Date : 2025-06-24
Patent Expiration Date : 2025-06-24
US Patent Number : 7790705
Drug Substance Claim :
Drug Product Claim :
Application Number : 50808
Patent Use Code : U-1078
Delist Requested :
Patent Use Description : TREATMENT OF ACNE
Patent Expiration Date : 2025-06-24
Patent Expiration Date : 2025-06-24
US Patent Number : 8252776
Drug Substance Claim :
Drug Product Claim :
Application Number : 50808
Patent Use Code : U-124
Delist Requested :
Patent Use Description : TREATMENT OF ACNE
Patent Expiration Date : 2025-06-24
Patent Expiration Date : 2027-03-07
US Patent Number : 7919483
Drug Substance Claim :
Drug Product Claim :
Application Number : 50808
Patent Use Code : U-1078
Delist Requested :
Patent Use Description : TREATMENT OF ACNE
Patent Expiration Date : 2027-03-07
LOOKING FOR A SUPPLIER?